Acetarsol

Acetarsol
Names
Preferred IUPAC name
(3-Acetamido-4-hydroxyphenyl)arsonic acid
Other names
Acetarsone
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard 100.002.349
EC Number
  • 202-582-3
KEGG
MeSH Acetarsol
UNII
UN number 3465
  • InChI=1S/C8H10AsNO5/c1-5(11)10-7-4-6(9(13,14)15)2-3-8(7)12/h2-4,12H,1H3,(H,10,11)(H2,13,14,15) Y
    Key: ODFJOVXVLFUVNQ-UHFFFAOYSA-N Y
  • InChI=1/C8H10AsNO5/c1-5(11)10-7-4-6(9(13,14)15)2-3-8(7)12/h2-4,12H,1H3,(H,10,11)(H2,13,14,15)
    Key: ODFJOVXVLFUVNQ-UHFFFAOYAX
  • CC(=O)Nc1cc(ccc1O)[As](O)(O)=O
  • CC(=O)NC1=CC(=CC=C1O)[As](O)(O)=O
Properties
C8H10AsNO5
Molar mass 275.0903 g mol−1
Pharmacology
A07AX02 (WHO) G01AB01 (WHO), P01CD02 (WHO), P51AD05 (WHO)
Hazards
GHS labelling:
Danger
H301, H331, H410
P261, P273, P301+P310, P311, P501
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

Acetarsol (or acetarsone, also known as spirocid) is an anti-infective drug. It was first discovered in 1921 at Pasteur Institute by Ernest Fourneau, and sold under the brand name Stovarsol. It was available in oral form and also as a suppository. It has been cancelled and withdrawn from the market since August 12, 1997.

Acetarsol can be used to make arsthinol.